Description:

AMC-061 Enrollment Form (ENR) NCT00890747 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6DBDC738-44D1-D324-E040-BB89AD433B23

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6DBDC738-44D1-D324-E040-BB89AD433B23

Keywords:
Versions (3) ▾
  1. 8/26/12
  2. 7/8/15
  3. 7/8/15
Uploaded on:

July 8, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

AMC-061 Enrollment Form (ENR) NCT00890747

No Instruction available.

  1. StudyEvent: AMC-061 Enrollment Form (ENR)
    1. No Instruction available.
Header Module
Inclusion/exclusion Criteria
Inclusion Criteria
Exclusion Criteria
Type of Cancer
Patient HAART regimen type?
%
Exclusion Criteria
Consent For Participation In Pharmacogenetics Study And The Use Of Future Tissue Specimens
Does the participant agree to participate in the pharmacogenetics study associated with this protocol
Does the participant agree to have excess specimens from this study stored for future AIDS-related research (or leftover)
Comments